Open AccessUpdated Results of TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathological Complete Response to Pertuzumab and Trastuzumab in Breast Cancer
Author(s) -
R.M. Connolly,
J.P. Leal,
L. Solnes,
C.-Y. Huang,
A. Carpenter,
K. Gaffney,
V. Abramson,
Lisa A. Carey,
M.C. Liu,
M. Rimawi,
J. Specht,
A.M. Storniolo,
V. Valero,
C. Vaklavas,
I.E. Krop,
E.P. Winer,
M. Camp,
R.S. Miller,
A.C. Wolff,
A. Cimino-Mathews,
B.H. Park,
R.L. Wahl,
V. Stearns
Publication year - 2021
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/brnf-1571
Subject(s) - pertuzumab , trastuzumab , oncology , breast cancer , medicine , pathological , cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom